Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Orifice Endoscopic Surgery | 8 | 2023 | 25 | 1.820 |
Why?
|
| Esophageal Achalasia | 6 | 2023 | 21 | 1.730 |
Why?
|
| Heller Myotomy | 3 | 2021 | 5 | 1.160 |
Why?
|
| Stomach | 3 | 2010 | 56 | 1.130 |
Why?
|
| Endoscopy, Gastrointestinal | 4 | 2015 | 96 | 0.930 |
Why?
|
| Colonoscopy | 2 | 2016 | 90 | 0.920 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 5 | 2016 | 34 | 0.830 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 6 | 0.820 |
Why?
|
| Health Resources | 1 | 2021 | 70 | 0.780 |
Why?
|
| Sphincterotomy, Endoscopic | 2 | 2016 | 5 | 0.750 |
Why?
|
| Ascites | 1 | 2019 | 20 | 0.720 |
Why?
|
| Gastroscopy | 4 | 2021 | 19 | 0.720 |
Why?
|
| Inpatients | 1 | 2021 | 250 | 0.670 |
Why?
|
| Adenoma | 2 | 2015 | 55 | 0.660 |
Why?
|
| Patient Compliance | 2 | 2016 | 331 | 0.620 |
Why?
|
| Patient Readmission | 1 | 2021 | 343 | 0.610 |
Why?
|
| Quality Indicators, Health Care | 2 | 2016 | 307 | 0.570 |
Why?
|
| Barrett Esophagus | 1 | 2015 | 22 | 0.570 |
Why?
|
| Liver Cirrhosis | 2 | 2014 | 107 | 0.570 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2015 | 3 | 0.550 |
Why?
|
| Ampulla of Vater | 1 | 2015 | 10 | 0.550 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 68 | 0.540 |
Why?
|
| Esophageal Neoplasms | 1 | 2015 | 64 | 0.540 |
Why?
|
| Catheter Ablation | 1 | 2015 | 56 | 0.520 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 209 | 0.490 |
Why?
|
| Life Style | 1 | 2015 | 310 | 0.490 |
Why?
|
| Surgical Instruments | 2 | 2010 | 30 | 0.470 |
Why?
|
| Disease Progression | 2 | 2015 | 738 | 0.470 |
Why?
|
| Esophageal Motility Disorders | 2 | 2023 | 6 | 0.470 |
Why?
|
| Quality of Health Care | 2 | 2014 | 468 | 0.450 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 316 | 0.450 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 141 | 0.430 |
Why?
|
| Esophageal Sphincter, Lower | 4 | 2023 | 14 | 0.430 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 455 | 0.430 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 234 | 0.410 |
Why?
|
| Middle Aged | 15 | 2021 | 13354 | 0.410 |
Why?
|
| Pamphlets | 1 | 2010 | 11 | 0.390 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 271 | 0.390 |
Why?
|
| Suture Anchors | 1 | 2009 | 5 | 0.380 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2010 | 74 | 0.380 |
Why?
|
| Aged | 12 | 2021 | 10836 | 0.370 |
Why?
|
| Drainage | 3 | 2016 | 104 | 0.320 |
Why?
|
| Brucellosis | 1 | 2007 | 3 | 0.320 |
Why?
|
| Pancreatic Diseases | 1 | 2007 | 26 | 0.320 |
Why?
|
| Treatment Outcome | 8 | 2023 | 3910 | 0.320 |
Why?
|
| Postoperative Hemorrhage | 2 | 2018 | 27 | 0.320 |
Why?
|
| Pancreatitis, Chronic | 1 | 2007 | 18 | 0.320 |
Why?
|
| Male | 15 | 2023 | 23069 | 0.310 |
Why?
|
| Anxiety | 1 | 2010 | 339 | 0.310 |
Why?
|
| Humans | 22 | 2023 | 49910 | 0.300 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 440 | 0.290 |
Why?
|
| Swine | 4 | 2010 | 293 | 0.290 |
Why?
|
| Hemorrhage | 1 | 2007 | 230 | 0.280 |
Why?
|
| Female | 16 | 2023 | 26358 | 0.280 |
Why?
|
| Gastrostomy | 3 | 2010 | 22 | 0.280 |
Why?
|
| Postoperative Complications | 4 | 2021 | 878 | 0.260 |
Why?
|
| Adult | 10 | 2021 | 13251 | 0.260 |
Why?
|
| Retrospective Studies | 4 | 2022 | 4575 | 0.250 |
Why?
|
| Esophageal Spasm, Diffuse | 1 | 2022 | 3 | 0.230 |
Why?
|
| Myotomy | 1 | 2022 | 6 | 0.230 |
Why?
|
| Referral and Consultation | 2 | 2016 | 347 | 0.230 |
Why?
|
| Argon Plasma Coagulation | 1 | 2021 | 2 | 0.210 |
Why?
|
| Gastric Antral Vascular Ectasia | 1 | 2021 | 4 | 0.210 |
Why?
|
| Hospital Charges | 1 | 2021 | 20 | 0.200 |
Why?
|
| Palliative Care | 2 | 2013 | 111 | 0.200 |
Why?
|
| Stents | 2 | 2016 | 327 | 0.200 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 74 | 0.190 |
Why?
|
| Length of Stay | 2 | 2021 | 607 | 0.190 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 55 | 0.190 |
Why?
|
| Suture Techniques | 2 | 2010 | 72 | 0.190 |
Why?
|
| Pancreatic Pseudocyst | 2 | 2010 | 10 | 0.190 |
Why?
|
| Pressure | 2 | 2010 | 62 | 0.190 |
Why?
|
| Esophagoscopy | 2 | 2018 | 21 | 0.180 |
Why?
|
| Risk Factors | 2 | 2021 | 4288 | 0.180 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 2160 | 0.180 |
Why?
|
| Massachusetts | 2 | 2016 | 1978 | 0.170 |
Why?
|
| Manometry | 1 | 2018 | 11 | 0.170 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 738 | 0.170 |
Why?
|
| Pancreatitis | 2 | 2016 | 79 | 0.170 |
Why?
|
| Heart Arrest | 2 | 2018 | 111 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2021 | 717 | 0.160 |
Why?
|
| Emphysema | 1 | 2016 | 7 | 0.160 |
Why?
|
| Insufflation | 1 | 2016 | 10 | 0.160 |
Why?
|
| Retroperitoneal Space | 1 | 2016 | 16 | 0.160 |
Why?
|
| Peritoneum | 1 | 2016 | 28 | 0.150 |
Why?
|
| Bile Duct Neoplasms | 2 | 2014 | 19 | 0.150 |
Why?
|
| Hospital Mortality | 1 | 2021 | 705 | 0.150 |
Why?
|
| Early Diagnosis | 1 | 2016 | 77 | 0.150 |
Why?
|
| United States | 2 | 2021 | 6294 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2021 | 1568 | 0.150 |
Why?
|
| Pneumopericardium | 1 | 2015 | 2 | 0.140 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 72 | 0.140 |
Why?
|
| Disease Management | 1 | 2016 | 172 | 0.140 |
Why?
|
| Neoplasm, Residual | 1 | 2015 | 35 | 0.130 |
Why?
|
| Common Bile Duct | 1 | 2014 | 16 | 0.130 |
Why?
|
| Dilatation, Pathologic | 1 | 2014 | 21 | 0.130 |
Why?
|
| Cholangiocarcinoma | 1 | 2014 | 10 | 0.130 |
Why?
|
| Gastroenterology | 1 | 2014 | 45 | 0.130 |
Why?
|
| Endosonography | 1 | 2013 | 26 | 0.120 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 53 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 346 | 0.120 |
Why?
|
| Time Factors | 1 | 2021 | 3138 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2018 | 2555 | 0.120 |
Why?
|
| Models, Animal | 2 | 2010 | 198 | 0.120 |
Why?
|
| Catheterization | 2 | 2010 | 86 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 4148 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2015 | 862 | 0.110 |
Why?
|
| Mass Screening | 1 | 2016 | 540 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2014 | 2074 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 830 | 0.100 |
Why?
|
| Surgical Stapling | 1 | 2010 | 7 | 0.100 |
Why?
|
| Smoking | 1 | 2015 | 746 | 0.100 |
Why?
|
| Meperidine | 1 | 2010 | 4 | 0.100 |
Why?
|
| Sutures | 1 | 2010 | 34 | 0.100 |
Why?
|
| Midazolam | 1 | 2010 | 10 | 0.100 |
Why?
|
| Transducers | 1 | 2010 | 19 | 0.100 |
Why?
|
| Abdominal Wall | 1 | 2010 | 17 | 0.100 |
Why?
|
| Anti-Anxiety Agents | 1 | 2010 | 31 | 0.100 |
Why?
|
| Narcotics | 1 | 2010 | 46 | 0.100 |
Why?
|
| Single-Blind Method | 1 | 2010 | 110 | 0.090 |
Why?
|
| Equipment Design | 1 | 2010 | 264 | 0.090 |
Why?
|
| Physicians | 1 | 2014 | 391 | 0.090 |
Why?
|
| Cholestasis | 1 | 2009 | 43 | 0.090 |
Why?
|
| Animals | 4 | 2010 | 17853 | 0.090 |
Why?
|
| Surgical Staplers | 1 | 2008 | 5 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 1931 | 0.090 |
Why?
|
| Survival Rate | 1 | 2010 | 649 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 194 | 0.080 |
Why?
|
| Hospitalization | 1 | 2014 | 1083 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2010 | 761 | 0.080 |
Why?
|
| Brunner Glands | 1 | 2007 | 2 | 0.080 |
Why?
|
| Cysts | 1 | 2007 | 34 | 0.080 |
Why?
|
| Esophagogastric Junction | 1 | 2023 | 11 | 0.060 |
Why?
|
| Electric Impedance | 1 | 2023 | 25 | 0.060 |
Why?
|
| Patient Selection | 2 | 2018 | 348 | 0.060 |
Why?
|
| Ligation | 1 | 2021 | 26 | 0.050 |
Why?
|
| Hematocrit | 1 | 2021 | 34 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2021 | 88 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2021 | 117 | 0.050 |
Why?
|
| Alloys | 2 | 2010 | 25 | 0.050 |
Why?
|
| Operative Time | 1 | 2018 | 49 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2018 | 38 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2018 | 168 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2018 | 137 | 0.040 |
Why?
|
| Recurrence | 1 | 2018 | 488 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1166 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2014 | 397 | 0.030 |
Why?
|
| Viscera | 1 | 2010 | 10 | 0.030 |
Why?
|
| Cholelithiasis | 1 | 2010 | 17 | 0.020 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2010 | 41 | 0.020 |
Why?
|
| Terminally Ill | 1 | 2009 | 15 | 0.020 |
Why?
|
| Stainless Steel | 1 | 2009 | 15 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2009 | 49 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 155 | 0.020 |
Why?
|
| International Cooperation | 1 | 2009 | 81 | 0.020 |
Why?
|
| Mouth | 1 | 2008 | 29 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2009 | 163 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 69 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 355 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 365 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 464 | 0.020 |
Why?
|
| Intestinal Polyps | 1 | 2007 | 7 | 0.020 |
Why?
|
| Gastritis | 1 | 2007 | 17 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2010 | 315 | 0.020 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 49 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 1228 | 0.020 |
Why?
|
| Quality of Life | 1 | 2009 | 779 | 0.020 |
Why?
|